Related Experiment Video
Updated: Jun 9, 2025

Author Spotlight: Exploring Breathing Techniques and Digital Solutions for Enhancing Running Performance
Published on: September 27, 2024
Smartphone Apps for Pulmonary Hypertension: Systematic Search and Content Evaluation
Nerea Báez Gutiérrez1, Héctor Rodríguez Ramallo2, Elva María Mendoza-Zambrano3
1Pharmacy Department, Hospital Universitario Virgen Macarena, Seville, Spain.
Mobile health apps for pulmonary hypertension (PH) are emerging, offering acceptable quality but needing refinement. Health care professional involvement significantly improves app quality, emphasizing the need for clinical validation and patient-centered design.
Area of Science:
- Medical Informatics
- Digital Health
- Pulmonary Medicine
Background:
- Pulmonary hypertension (PH) is a chronic condition requiring ongoing patient and healthcare professional (HCP) education and management.
- Smartphone-based mobile health (mHealth) applications offer potential for improved PH monitoring and management.
Purpose of the Study:
- To identify and evaluate the quality of free mHealth apps for pulmonary hypertension (PH) available to patients and HCPs.
- To assess changes in app availability and quality between 2022 and 2023.
Main Methods:
- Systematic search of free PH apps on Android and iOS platforms from a Spanish IP address in October 2022 and 2023.
- Independent app analysis by two reviewers using the Mobile Application Rating Scale (MARS) framework.
- Statistical comparison of MARS scores using Mann-Whitney U tests.
Main Results:
- 21 unique PH apps were identified across both years; only 7 were updated between 2022 and 2023.
- Overall mean MARS quality was acceptable (3.1 in 2022, 3.3 in 2023), with functionality scoring highest and subjective quality lowest.
- iOS apps outperformed Android apps, and apps developed with HCP involvement showed significantly higher quality.
Conclusions:
- Current mHealth apps for PH are in early development, with generally acceptable but unrefined quality.
- HCP involvement is crucial for enhancing app quality and reliability.
- A need exists for continuous innovation, patient input, and rigorous clinical validation for effective PH mHealth integration.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...

